Shahin Rafii Selected Research

Shahin Rafii Research Topics

Disease

40	Neoplasms (Cancer) 11/2021 - 12/2002
7	Neoplasm Metastasis (Metastasis) 11/2019 - 12/2002
6	Leukemia 01/2020 - 03/2002
4	Breast Neoplasms (Breast Cancer) 02/2016 - 10/2006
4	Carcinogenesis 01/2015 - 11/2003
4	Glioblastoma (Glioblastoma Multiforme) 01/2015 - 01/2007
3	Ovarian Neoplasms (Ovarian Cancer) 10/2019 - 12/2014
3	Fibrosis (Cirrhosis) 10/2017 - 02/2016
3	Liver Cirrhosis (Hepatic Cirrhosis) 10/2017 - 12/2016
3	Vascular Remodeling 12/2016 - 03/2003
3	Ischemia 10/2013 - 03/2005
3	Hypoxia (Hypoxemia) 11/2010 - 05/2006
3	Infections 05/2005 - 04/2002
3	Cardiovascular Diseases (Cardiovascular Disease) 03/2004 - 05/2002
2	COVID-19 01/2022 - 11/2020
2	Vascular Diseases (Vascular Disease) 01/2020 - 10/2003
2	Inflammation (Inflammations) 11/2019 - 06/2008
2	Glioma (Gliomas) 05/2017 - 05/2009
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2016 - 11/2008
2	Wounds and Injuries (Trauma) 05/2011 - 01/2010
2	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 03/2010 - 09/2009
2	Cicatrix (Scar) 01/2010 - 03/2004
2	Hyperplasia 06/2009 - 10/2006
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2008 - 01/2004
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022
1	Vascular System Injuries 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	Emphysema 01/2021
1	Microvascular Rarefaction 01/2021
1	Cytokine Release Syndrome 01/2017
1	Thrombosis (Thrombus) 12/2016
1	Cholestasis 12/2016
1	Pancytopenia 12/2016
1	Radiation Injuries (Radiation Sickness) 08/2016
1	Insulin Resistance 04/2016
1	Obesity 04/2016
1	Reinjuries 02/2016
1	Lung Injury 02/2016

Drug/Important Bio-Agent (IBA)

15	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2016 - 03/2002
8	LigandsIBA 12/2016 - 10/2006
7	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 05/2009 - 04/2002
6	Proteins (Proteins, Gene)FDA Link 11/2019 - 04/2002
5	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 02/2016 - 04/2005
4	CytokinesIBA 11/2019 - 03/2002
4	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 05/2017 - 04/2005
3	Biomarkers (Surrogate Marker)IBA 10/2017 - 01/2007
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017 - 10/2004
3	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 12/2014 - 03/2002
3	Oxygen (Dioxygen)IBA 01/2014 - 07/2010
3	Biological ProductsIBA 11/2012 - 03/2003
3	ChemokinesIBA 05/2011 - 07/2007
3	Matrix Metalloproteinases (MMPs)IBA 05/2007 - 03/2003
3	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 04/2005 - 03/2002
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2011
2	Imatinib Mesylate (Gleevec)FDA Link 01/2020 - 06/2011
2	tumor-derived adhesion factorIBA 01/2017 - 07/2009
2	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 12/2016 - 11/2012
2	CateninsIBA 02/2016 - 02/2016
2	cadherin 5IBA 02/2016 - 11/2005
2	beta CateninIBA 02/2016 - 11/2005
2	Small Interfering RNA (siRNA)IBA 02/2016 - 03/2007
2	Metalloproteases (Metalloproteinases)IBA 01/2016 - 03/2003
2	RNA (Ribonucleic Acid)IBA 02/2015 - 01/2015
2	Bevacizumab (Avastin)FDA Link 12/2014 - 06/2008
2	erucylphosphocholineIBA 01/2013 - 11/2008
2	AlginatesIBA 05/2011 - 01/2010
2	HydrogelsIBA 05/2011 - 01/2010
2	Monoclonal AntibodiesIBA 06/2008 - 10/2006
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 05/2007 - 05/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2007 - 01/2004
2	Fibronectins (Fibronectin)IBA 12/2006 - 12/2005
2	Stem Cell FactorIBA 05/2006 - 10/2003
2	matrigelIBA 03/2005 - 03/2004
1	Angiopoietin-2IBA 01/2022
1	Proto-Oncogene Proteins c-etsIBA 11/2021
1	Pancreatic Elastase (Elastase)IBA 01/2021
1	Leucine (L-Leucine)FDA Link 01/2021
1	Retinaldehyde (Retinal)IBA 01/2020
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2017
1	Phosphates (Orthophosphate)IBA 10/2017
1	Ethanol (Ethyl Alcohol)IBA 10/2017
1	Keratins (Keratin)IBA 10/2017
1	Iodized OilIBA 10/2017
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 05/2017
1	Insulin (Novolin)FDA Link 01/2017
1	Fibrinolysin FDA Link 01/2017
1	SEW2871IBA 12/2016
1	Vascular Endothelial Growth Factor BIBA 04/2016
1	Chemokine ReceptorsIBA 02/2016
1	Bleomycin (Blenoxane)FDA LinkGeneric 02/2016
1	Hydrochloric Acid (Hydrogen Chloride)FDA Link 02/2016

Therapy/Procedure

24	Therapeutics 01/2022 - 05/2002
5	Transplantation 12/2019 - 07/2003
5	Drug Therapy (Chemotherapy) 10/2019 - 03/2002
2	Radiotherapy 11/2020 - 05/2003
2	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2017 - 10/2003
2	Hepatectomy 12/2016 - 11/2010
1	Catheters 10/2017